These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8040113)

  • 21. Determination of the in vitro susceptibility of 220 Mycobacterium fortuitum isolates to ten antimicrobial agents.
    Hernández AM; Arias A; Felipe A; Alvarez R; Sierra A
    J Chemother; 1995 Dec; 7(6):503-8. PubMed ID: 8667033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of ciprofloxacin against Mycobacteria in vitro: comparison of BACTEC and macrobroth dilution methods.
    Trimble KA; Clark RB; Sanders WE; Frankel JW; Cacciatore R; Valdez H
    J Antimicrob Chemother; 1987 May; 19(5):617-22. PubMed ID: 3112096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiometric susceptibility testing of Mycobacterium xenopi.
    Tortoli E; Simonetti MT
    J Chemother; 1995 Apr; 7(2):114-7. PubMed ID: 7666116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro antibiotic susceptibility of rapidly growing nontuberculous mycobacteria isolated from patients with microbial keratitis.
    Reddy AK; Garg P; Babu KH; Gopinathan U; Sharma S
    Curr Eye Res; 2010 Mar; 35(3):225-9. PubMed ID: 20373881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial susceptibility of standard strains of nontuberculous mycobacteria by microplate Alamar Blue assay.
    Li G; Lian LL; Wan L; Zhang J; Zhao X; Jiang Y; Zhao LL; Liu H; Wan K
    PLoS One; 2013; 8(12):e84065. PubMed ID: 24386332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sulfonamide activity against Mycobacterium fortuitum and Mycobacterium chelonei.
    Wallace RJ; Jones DB; Wiss K
    Rev Infect Dis; 1981; 3(5):898-904. PubMed ID: 7339821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a new method for rapid drug susceptibility testing of Mycobacterium avium complex isolates by using the mycobacteria growth indicator tube.
    Piersimoni C; Nista D; Bornigia S; De Sio G
    J Clin Microbiol; 1998 Jan; 36(1):64-7. PubMed ID: 9431921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility testing of Mycobacterium abscessus by isothermal microcalorimetry.
    Boillat-Blanco N; Furustrand Tafin U; Jaton K; Trampuz A
    Diagn Microbiol Infect Dis; 2015 Oct; 83(2):139-43. PubMed ID: 26210204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison between disk diffusion and microdilution for susceptibility testing of Mycobacterium fortuitum complex.
    Esteban J; Gadea I; Torres MV; Cabria F; Rollan E; Santos-O'Connor FG; Fernández-Roblas R; Soriano F
    J Chemother; 2002 Dec; 14(6):547-53. PubMed ID: 12583544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro susceptibility of Mycobacterium fortuitum to cefoxitin.
    Cynamon MH; Patapow A
    Antimicrob Agents Chemother; 1981 Jan; 19(1):205-7. PubMed ID: 7247358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug susceptibility of rapid and slow growing non-tuberculous mycobacteria isolated from symptomatics for pulmonary tuberculosis, Central India.
    Goswami B; Narang P; Mishra PS; Narang R; Narang U; Mendiratta DK
    Indian J Med Microbiol; 2016; 34(4):442-447. PubMed ID: 27934821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods.
    Moody JA; Gerding DN; Peterson LR
    Am J Med; 1987 Apr; 82(4A):44-54. PubMed ID: 3107380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time-kill kinetics of antibiotics active against rapidly growing mycobacteria.
    Ferro BE; van Ingen J; Wattenberg M; van Soolingen D; Mouton JW
    J Antimicrob Chemother; 2015 Mar; 70(3):811-7. PubMed ID: 25344808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.
    Mougari F; Loiseau J; Veziris N; Bernard C; Bercot B; Sougakoff W; Jarlier V; Raskine L; Cambau E;
    J Antimicrob Chemother; 2017 Jun; 72(6):1669-1677. PubMed ID: 28333340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotic resistance in
    Jayasingam SD; Zin T; Ngeow YF
    Int J Mycobacteriol; 2017; 6(4):387-390. PubMed ID: 29171453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug susceptibility testing of nontuberculous mycobacteria.
    van Ingen J; Kuijper EJ
    Future Microbiol; 2014; 9(9):1095-110. PubMed ID: 25340838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial susceptibility of nontuberculous mycobacteria from eye infections.
    Brown-Elliott BA; Mann LB; Hail D; Whitney C; Wallace RJ
    Cornea; 2012 Aug; 31(8):900-6. PubMed ID: 22362004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the E test and a proportion dilution method for susceptibility testing of Mycobacterium kansasii.
    Fabry W; Schmid EN; Ansorg R
    Chemotherapy; 1995; 41(4):247-52. PubMed ID: 7555204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial susceptibility testing of rapidly growing mycobacteria by microdilution - experience of a tertiary care centre.
    Set R; Rokade S; Agrawal S; Shastri J
    Indian J Med Microbiol; 2010; 28(1):48-50. PubMed ID: 20061764
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Brown-Elliott BA; Wallace RJ
    J Clin Microbiol; 2017 Jun; 55(6):1747-1754. PubMed ID: 28330892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.